Paclitaxel

Red

Brand Name(s):

Indication:Ovarian Cancer

Rationale:1,2,3,8

Considered:Jan-11

Review Date:Jan-26

Comments:
NICE TA389
Paclitaxel in combination with platinum or as monotherapy is recommended within its marketing authorisation as an option for treating recurrent ovarian cancer